Neuroprotective effect of ginsenoside Rg1 prevents cognitive impairment induced by isoflurane anesthesia in aged rats via antioxidant, anti-inflammatory and anti-apoptotic effects mediated by the PI3K/AKT/GSK-3β pathway

Aug 4, 2016Molecular medicine reports

Ginsenoside Rg1 may protect older rats from memory loss caused by isoflurane anesthesia through antioxidant, anti-inflammatory, and cell survival pathways

AI simplified

Abstract

Ginsenoside Rg1 at 20 mg/kg significantly improved cognitive function in aged rats exposed to isoflurane anesthesia.

  • Ginsenoside Rg1 may exert neuroprotective effects by reducing cognitive impairment associated with isoflurane anesthesia.
  • The treatment is linked to antioxidant and anti-inflammatory effects in the brain.
  • Caspase-3 activity was significantly reduced, indicating a potential role in preventing cell death.
  • Ginsenoside Rg1 upregulated the expression of the PI3K/AKT/GSK-3β pathway components.
  • The expression levels of p21WAF1/CIP1 and p53 were downregulated in response to ginsenoside Rg1 treatment.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free